Loading clinical trials...
Loading clinical trials...
Find 127 clinical trials for alzheimer's disease near Philadelphia, Pennsylvania. Connect with research centers in your area.
Showing 101-120 of 127 trials
NCT02051790
This study is designed to evaluate the agreement between florbetapir F 18 scan interpretation in the clinic and by expert readers.
NCT01021644
The primary purpose of this pilot study is to determine whether African Americans with mild Alzheimer's disease (AD) can be enrolled and retained in a 6-month aerobic exercise-training study.
NCT00575055
This is a multicenter, double-blind, placebo controlled, randomized, outpatient, multiple dose study in male and female patients ages 50 to less than 89 years with mild to moderate AD. Approximately 200 study sites in the US and Canada will be involved. Patients will be randomized to receive either bapineuzumab or placebo. Each patient's participation will last approximately 1.5 years. Bapineuzumab is a humanized monoclonal antibody, which binds to and clears beta amyloid peptide, and is designed to provide antibodies to beta amyloid directly to the patient.